| HOME >> BIOLOGY >> TECHNOLOGY |
Share-based compensation (9,327) (13,338) (1,780)
GAAP operating income 96,923 154,582 20,631
GAAP operating margin 26.9% 27.0% 27.0%
Non-GAAP gross profit 201,291 320,985 42,839
Non-GAAP gross margin 55.8% 56.0% 56.0%
Expense/Amortization of acquired
intangible assets -- (4,707) (628)
Share-based compensation (190) (411) (55)
GAAP gross profit 201,101 315,867 42,156
GAAP gross margin 55.7% 55.1% 55.1%
Exhibit 3
MINDRAY MEDICAL INTERNATIONAL LIMITED
RECONCILIATIONS OF NON-GAAP RESULTS OF OPERATIONS MEASURES TO THE NEAREST
COMPARABLE GAAP MEASURES
Nine months ended September 30,
2006 2007 2007
RMB RMB US$
(unaudited) (unaudited) (unaudited)
(In thousands, except share and per
share data)
Non-GAAP net income (note 3) 275,332 486,607 64,943
Non-GAAP net margin 26.5% 31.3% 31.3%
Expense/Amortization of acquired
intangible assets -- (14,122) (1,885)
Deferred tax impact related to
acquired intangible assets -- 2,118 283
Share-based compensation (19,513) (40,946) (5,465)
GAAP net income 255,819 433,657 57,876
GAAP net margin
'/>"/>
| SOURCE Mindray Medical International Limited Copyright©2007 PR Newswire. All rights reserved |